Press "Enter" to skip to content

Tag: inflation

Season 2, Episode 30: The Real ‘Melt-Up Is Still Ahead of Us’

Published October 6, 2020

September was a “fake out sell off,” says David Hunter.

David Hunter of Contrarian Macro Advisors rejoins the podcast to update listeners on his vision of a “parabolic melt-up” in risk assets that will presage the next market crash.

What we’ve seen since late March was not the real melt-up, Hunter says. Most of the gains are still ahead, in fact the coming months should see the final (and most dramatic) period of the rally. Then things get ugly.

MoreSeason 2, Episode 30: The Real ‘Melt-Up Is Still Ahead of Us’
Leave a Comment

Season 2, Episode 15: Healthcare, Tech Stocks May Not Be As Defensive As Believed

Published May 13, 2020

With Chris Brown of Aristides Capital

Christopher Brown of Aristides Capital joins the podcast to discuss his investment strategy, which has produced positive returns every calendar year since 2008.

Update: This podcast episode has been transcribed! Read it here.

In Brown’s view, healthcare and information technology stocks should not be treated as defensive investments that will protect portfolios in times of stress — especially after their recent run-up. There are reasons many companies in this sector are overvalued and could see their shares drop as the economy begins to see further difficulties from coronavirus.

Aristides Capital has an active short book, which framed most of the second half of the conversation.  

Content Segments: 

  • Why investors’ thinking about defensive stocks may be misguided (4:49)
  • Growth stocks’ recent performance is reminiscent of the late-1990s tech bubble (7:05)
  • The concerns with healthcare stocks (11:45)
  • Background on the guest (15:07)
  • Some of the red flags short sellers look for and why the “big picture” is often more pertinent (20:22)
  • Inovio Pharmaceuticals (NASDAQ: INO) discussion (22:52)
  • CytoDyn Inc. (OTC: CYDY) discussion (25:44)
  • Vuzix Corp. (NASDAQ: VUZI) discussion (28:37)
  • Accelerate Diagnostics (NASDAQ: AXDX) discussion (30:59)
  • Insider purchases are not always a bullish indicator (35:02)
  • Tesla Inc. (NASDAQ: TSLA) discussion, at the guest’s suggestion (host didn’t want to go there originally) and why it could be an indicator for future market direction (36:17)
  • Reasons to be bearish on markets and the economy (39:17)
  • How to protect your portfolio against inflation (42:13)

Highlights From Our YouTube Channel

For more information on the guest:

Not intended as investment advice.

Leave a Comment

Season 2, Episode 1: The Next Market Meltdown is Coming

Published January 16, 2020

Sunrise Capital’s Chris Stanton on the What, When, and Where

Chris Stanton, chief investment officer at Sunrise Capital, rejoins the podcast to discuss his bearish views on the market at the start of 2020.

There are reasons to believe a market correction is overdue, Stanton says. Risk is everywhere: geopolitical, volatility, repo markets. A drop of 18% to 20% can be expected before March 31.

Highlights:

  • “Rest assured, we’re heading for a correction and I would argue it’s going to be terrifying when it comes” (5:43)
  • The “Phase 1” deal with China is a temporary measure that will be revoked if Donald Trump wins reelection in November (9:55)
  • A likely catalyst for a correction is in the repo market (11:36)
  • A “volatility-led sell off” is likely before the end of the first quarter (16:12)
  • Where’s inflation? (26:34)
  • It may not take an actual headline for investors to decide equities are overbought (31:01)
  • Background on Stanton’s firm, San Diego-based Sunrise Capital (38:03)
  • The “origin story”: Background on Stanton himself (53:03)
  • What should retail investors do, right now? (1:02:49)

Highlights From Our YouTube Channel

For more information on Sunrise Capital: www.sunrisecapital.com

Not intended as investment advice.

Leave a Comment